Aeolus Pharmaceuticals Inc. announced consolidated earnings results for the fourth quarter and full year ended September 30, 2015. For the fourth quarter of fiscal year 2015, total revenues were $934,000 as compared to $2,417,000 in the fourth quarter of fiscal year 2014. Net loss for the fourth quarter in fiscal year 2015 was $434,000 or $0.00 per share as compared to $524,000 or $0.00 per share in the fourth quarter of fiscal year 2014.

For the year, the company reported contract revenue of $3,111,000 compared to $9,631,000 a year ago. Loss from operations was $2,626,000 compared to $80,000 a year ago. Net loss was $2,628,000 or $0.02 per basic and diluted share compared to $80,000 or $0.00 per basic and diluted share a year ago. Diluted net loss attributable to common stockholders was $2,628,000 compared to $80,000 a year ago. Net cash used in operating activities was $2,443,000 compared to net cash provided by operating activities of $323,000 a year ago.